Literature DB >> 8109951

Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamase genes.

L B Rice1, S H Marshall, L L Carias, L Sutton, G A Jacoby.   

Abstract

Genes for MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamases have been cloned and sequenced. The gene for MGH-1 has the sequence of blaTEM-10, YOU-2 has that of blaTEM-12, and YOU-1 has that of blaTEM-26. All have evolved from blaTEM-1b but have the strong dual promoter sequence of blaTEM-2.

Mesh：

Substances：

Year:  1993        PMID： 8109951      PMCID： PMC192806          DOI： 10.1128/AAC.37.12.2760

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 beta-lactamase genes.

Authors:  C Chanal; M C Poupart; D Sirot; R Labia; J Sirot; R Cluzel
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

2.  Sequence of the PSE-1 beta-lactamase gene.

Authors:  P Huovinen; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

3.  Variations between the nucleotide sequences of Tn1, Tn2, and Tn3 and expression of beta-lactamase in Pseudomonas aeruginosa and Escherichia coli.

Authors:  S T Chen; R C Clowes
Journal:  J Bacteriol       Date:  1987-02       Impact factor: 3.490

4.  Broad-spectrum, transmissible beta-lactamases.

Authors:  G A Jacoby; A A Medeiros; T F O'Brien; M E Pinto; H Jiang
Journal:  N Engl J Med       Date:  1988-09-15       Impact factor: 91.245

5.  Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322.

Authors:  J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

6.  Selective ceftazidime resistance in Escherichia coli: association with changes in outer membrane protein.

Authors:  J S Bakken; C C Sanders; K S Thomson
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

7.  Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences.

Authors:  B A Rasmussen; P A Bradford; J P Quinn; J Wiener; R A Weinstein; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients.

Authors:  L Naumovski; J P Quinn; D Miyashiro; M Patel; K Bush; S B Singer; D Graves; T Palzkill; A M Arvin
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

10.  Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens.

Authors:  G A Jacoby; M J Blaser; P Santanam; H Hächler; F H Kayser; R S Hare; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191
View more
  18 in total

Review 1.  Beta-lactamase nomenclature.

Authors:  George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

2.  Survey of Klebsiella pneumoniae producing extended-spectrum beta-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France.

Authors:  M J Soilleux; A M Morand; G J Arlet; M R Scavizzi; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

3.  Updated sequence information for TEM beta-lactamase genes.

Authors:  S Goussard; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

4.  Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find.

Authors:  P E Coudron; E S Moland; C C Sanders
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

5.  Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae.

Authors:  L Martínez-Martínez; A Pascual; S Hernández-Allés; D Alvarez-Díaz; A I Suárez; J Tran; V J Benedí; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

6.  Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae.

Authors:  C Thauvin-Eliopoulos; M F Tripodi; R C Moellering; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 7.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

8.  In vivo efficacies of beta-lactam-beta-lactamase inhibitor combinations against a TEM-26-producing strain of Klebsiella pneumoniae.

Authors:  L B Rice; L L Carias; D M Shlaes
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

9.  Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.

Authors:  P A Bradford; C E Cherubin; V Idemyor; B A Rasmussen; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

10.  Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?

Authors:  E S Moland; C C Sanders; K S Thomson
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.